Image from Google Jackets

Good clinical practices in pharmaceuticals / edited by Graham P. Bunn.

Contributor(s): Material type: TextTextBoca Raton : CRC Press, 2025Description: xv, 666 pages : colored illustrations ; 28 cmContent type:
  • text
Media type:
  • unmediated
Carrier type:
  • volume
ISBN:
  • 9781032524078
Subject(s): LOC classification:
  • Allied RS 100.5 G66 2025
Contents:
ch. 1. FDA submission requirements -- ch. 2. Principles of good clinical practice (GCP) -- ch. 3. Quality by design, critical to quality -- ch. 4. Good clinical practice, Modernizing ICH E6 -- ch. 5. Good clinical safety practice -- ch. 6. Informed consent -- ch. 7. Financial disclosure by clinical investigators -- ch. 8. Institutional review boards -- ch. 9. Protected health information and privacy in clinical trials -- ch. 10. Good pharmacovigilance practices (GVP) -- ch. 11. Electronic records, electronic signature and data integrity -- ch. 12. Preparing for FDA inspections at the sponsore -- ch. 13. Regulations relating to the placebo response in clinical research
List(s) this item appears in: EAC Library Cavite - Pharmacy
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Status Barcode
Books EAC Library Cavite EAC Cavite-Allied Health Sciences Section Allied RS 100.5 G66 2025 (Browse shelf(Opens below)) Available ML19452

Includes index

ch. 1. FDA submission requirements -- ch. 2. Principles of good clinical practice (GCP) -- ch. 3. Quality by design, critical to quality -- ch. 4. Good clinical practice, Modernizing ICH E6 -- ch. 5. Good clinical safety practice -- ch. 6. Informed consent -- ch. 7. Financial disclosure by clinical investigators -- ch. 8. Institutional review boards -- ch. 9. Protected health information and privacy in clinical trials -- ch. 10. Good pharmacovigilance practices (GVP) -- ch. 11. Electronic records, electronic signature and data integrity -- ch. 12. Preparing for FDA inspections at the sponsore -- ch. 13. Regulations relating to the placebo response in clinical research

There are no comments on this title.

to post a comment.